Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy

Background: The therapeutic strategy of invasive breast cancer is based on routine histopathological markers (estrogen-, progesterone receptor, HER2, Ki67) routinely evaluated in tumor cells. However, the assessment of cancer stroma could influence therapeutic strategies. Studies have shown that str...

Descripción completa

Detalles Bibliográficos
Autores principales: Olah, Orsolya, Majlat, Edit, Koszo, Renata, Vereb, Zoltan, Voros, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849231/
https://www.ncbi.nlm.nih.gov/pubmed/36685105
http://dx.doi.org/10.3389/pore.2022.1610598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849231/
https://www.ncbi.nlm.nih.gov/pubmed/36685105
http://dx.doi.org/10.3389/pore.2022.1610598

Ejemplares similares